Skip to main content

Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer's disease.

Harrison PJ, Barton AJ, Najlerahim A, McDonald B, Pearson RC

Publication: Psychol Med (1991) • Vol 21 • Page 855-66PMID: 1685790View on PubMed

Purpose

The purpose of this paper was to examine the effect of postmortem interval (PMI) (6-86 h), rapidity of death, patient age, and Alzheimer's disease on polyadenylated (poly(A)) mRNA in situ hybridization signal in different brain regions.

Conclusion

PMI did not significantly alter quantifiable poly(A) mRNA levels in control (7-70 h) or Alzheimer's disease (6-86) brain specimens, although a nonsignificant reduction in poly(A) mRNA was observed with increasing PMI. Rapidity of death did not affect poly(A) levels in control brains, but prolonged coma and slow deterioration significantly reduced poly(A) in the visual cortex of Alzheimer's disease brain specimens. Advancing age led to a significant reduction in poly(A) in hippocampal regions CA1 and CA4 (51-96 y)of control specimens; similar, but nonsignificant, trends were also observed in other brain regions and in Alzheimer's disease specimens. Poly(A) mRNA levels were significantly lower in Alzheimer's disease specimens compared to normal controls (69-73% of normal controls) in the hippocampal region CA3, the granular layer of the cerebellum, and when examined at the cellular level in the temporal cortex. Similar, but nonsignificant, trends were observed among other brain regions and non-Alzheimer's dementia specimens. The authors conclude that poly(A) mRNA levels were not impacted by PMI, but may be influenced by rapidity of death, patient age and Alzheimer's disease.

Studies (2)

Purpose

The purpose of this study was to examine the effect of postmortem interval (PMI) (6-86 h), rapidity of death, and patient age on poly(A) mRNA levels, as quantified by in situ hybridization, in different brain regions. Of note, brain specimens were stored at -70 degrees C for 2-24 months prior to analysis.

Summary of Findings

PMI did not significantly alter quantifiable poly(A) mRNA levels in control (7-70 h) or Alzheimer's disease (6-86) brain specimens, although a nonsignificant reduction in poly(A) mRNA was observed with increasing PMI regardless of disease state (r = -0.04 to -0.48). No effect of rapidity of death was observed in control brain specimens, but prolonged coma or slow patient deterioration resulted in a decline in poly(A) signal in the visual cortex of Alzheimer's disease brain specimens. In control brains, advancing age (51-96 y) led to reduced poly(A) mRNA levels in hippocampal regions CA1 and CA4 (p<0.05); similar, but nonsignificant trends were also observed in other brain regions and in Alzheimer's disease specimens. The authors conclude that rapidity of death and patient age can alter poly(A) mRNA levels, but that any effect of PMI in the first 86 h is insignificant.
  • Biospecimens

    TissueBrain
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    Alzheimer's Disease
    Autopsy
    Huntington's Disease
    Other diagnoses
  • Platforms

    RNAIn situ hybridization
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Alzheimer's disease
    Control
    Non-Alzheimer's dementia
    PreaquisitionPatient age
    51-96 y
    PreaquisitionPostmortem interval
    6-86 h
    PreaquisitionRapidity of death
    Coma of less than 12 h or evidence of pyrexia or dehydration
    Coma of more than 12 h
    Sudden death
    Biospecimen AcquisitionBiospecimen location
    Dentate gyrus
    Granular layer of cerebellum
    Hippocampus region CA1
    Hippocampus region CA2
    Hippocampus region CA3
    Hippocampus region CA4
    Temporal cortex
    Visual cortex